|Articles|January 27, 2015
OIG Expects Tighter Control on Compounded Drugs in CMS-Approved Hospitals
OIG recommends training for inspectors and amending contracts with stand-alone pharmacies to ensure improved quality and safety.
Advertisement
More than 2 years after drugs contaminated with a virulent fungus killed 64 patients and caused related illnesses in another 687, Medicare-approved hospital accreditors still don't properly oversee contracts hospitals have with compounding pharmacies to assure these drugs are safe, according to an Office of Inspector General report.
It recommends CMS consider requiring 55 practices to use accreditors to oversee compounded sterile preparations.
Link to the complete article on Medpage Today:
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Andes Hantavirus FAQs: What to Know as Quarantined Cruise Passengers Return Home
2
Rituximab Suppresses Clinical Relapses, MRI Activity in Pediatric MS
3
New Therapies Offer Hope for Vitiligo, an Often Misunderstood and Undertreated Disease
4
FDA Issues Complete Response Letter for Cingulate's Once-Daily ADHD Drug CTx-1301
5